ONCOSIL FPO revenue breakdown overview

ONCOSIL FPO revenue for the last year amounted to 516.63 k AUD, the most of which — 516.63 k AUD — came from its highest performing source at the moment, Device Development for New Medical Treatments, the year earlier bringing 367.68 k AUD. The greatest contribution to the revenue figure was made by Europe — last year it brought ONCOSIL FPO 456.63 k AUD, and the year before that — 111.79 k AUD.